Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 16-Nov-2017

Harmonigenic Corporation

Abstract

Harmonigenic Corporation is developing central laboratory diagnostic service offering healthcare providers greater accuracy of metastasis prediction in cancer diagnosis using its patent-pending photonics assay technology. The goal is to assist doctors & patients with treatment decisions by diagnosing metastatic behavior in the primary tumor before distant recurrence is detected, ultimately reducing over-treatment in the majority who are not metastatic, improving patients’ quality of life, & decreasing healthcare costs.

Additional Questions

Investor questions have not yet been answered for this business